FDMT — 4D MOLECULAR THERAPEUTICS IN

Ownership history in BVF INC/IL · 21 quarters on record

This page tracks every 13F SEC filing in which BVF INC/IL reported a position in 4D MOLECULAR THERAPEUTICS IN (FDMT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

3.76% (2022 Q4)

Avg. % of fund

1.79%

First filed

2020 Q4

Last filed

2025 Q4

Quarters held

21

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q4	UNCHANGED	4,629,289	—	0%	1.17%	$34.7M	$7.50
2025 Q3	UNCHANGED	4,629,289	—	0%	1.63%	$40.2M	$8.69
2025 Q2	ADDED	4,629,289	+68,000	+1.5%	0.61%	$17.2M	$3.71
2025 Q1	ADDED	4,561,289	+1,890,647	+70.8%	0.60%	$14.7M	$3.23

% of Fund (quarterly) FDMT price (monthly, adj. close)

Other funds also holding FDMT

As of 2025 Q4 — sorted by position size

Novo Holdings A/S 3Y 7Y 2.13% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.43% Parkman Healthcare Partners LLC 3Y 0.36% Privium Fund Management B.V. 3Y 0.29% Rangeley Capital, LLC 0.24% ARMISTICE CAPITAL, LLC 3Y 7Y 0.17% Evergreen Quality Fund GP, Ltd. 0.14% Burkehill Global Management, LP 0.14% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 0.1% ArrowMark Colorado Holdings LLC 3Y 7Y 0.08%

← Back to BVF INC/IL Holdings